When the Trial Ends: The Case for Post-Trial Provisions in Clinical Psychedelic Research
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
When the Trial Ends: The Case for Post-Trial Provisions in Clinical Psychedelic Research
Authors
Keywords
-
Journal
Neuroethics
Volume 17, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-11-06
DOI
10.1007/s12152-023-09536-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Patient Safety and the Question of Dignitary Harms
- (2023) Polly Mitchell et al. JOURNAL OF MEDICINE AND PHILOSOPHY
- Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression
- (2022) Roberta Murphy et al. Frontiers in Pharmacology
- Using a MDMA- and LSD-Group Therapy Model in Clinical Practice in Switzerland and Highlighting the Treatment of Trauma-Related Disorders
- (2022) Peter Oehen et al. Frontiers in Psychiatry
- Psychedelics and Psychotherapy: Cognitive-Behavioral Approaches as Default
- (2022) David B. Yaden et al. Frontiers in Psychology
- Integration in Psychedelic-Assisted Treatments: Recurring Themes in Current Providers’ Definitions, Challenges, and Concerns
- (2022) Mitch Earleywine et al. JOURNAL OF HUMANISTIC PSYCHOLOGY
- Socio-psychedelic imaginaries: envisioning and building legal psychedelic worlds in the United States
- (2022) Claudia Schwarz-Plaschg European Journal of Futures Research
- The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world
- (2022) Rosalind Watts et al. PSYCHOPHARMACOLOGY
- Psychedelic integration: An analysis of the concept and its practice
- (2022) Geoff J. Bathje et al. Frontiers in Psychology
- Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review
- (2022) Joost J Breeksema et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Psychedelics therapeutics: What we know, what we think, and what we need to research.
- (2022) David Nutt et al. NEUROPHARMACOLOGY
- Therapeutic use of psilocybin: Practical considerations for dosing and administration
- (2022) Caroline A. MacCallum et al. Frontiers in Psychiatry
- Racial Justice Requires Ending the War on Drugs
- (2021) Brian D. Earp et al. AMERICAN JOURNAL OF BIOETHICS
- Trial of Psilocybin versus Escitalopram for Depression
- (2021) Robin Carhart-Harris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Assessing the effects of methodological differences on outcomes in the use of psychedelics in the treatment of anxiety and depressive disorders: A systematic review and meta-analysis
- (2021) Robert F Leger et al. JOURNAL OF PSYCHOPHARMACOLOGY
- New Frontiers or a Bursting Bubble? Psychedelic Therapy Beyond the Dichotomy
- (2021) Tehseen Noorani et al. Frontiers in Psychiatry
- Psychedelic Psychiatry’s Brave New World
- (2020) David Nutt et al. CELL
- A mechanistic model of the neural entropy increase elicited by psychedelic drugs
- (2020) Rubén Herzog et al. Scientific Reports
- Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern‐era clinical studies
- (2020) Kristoffer A. A. Andersen et al. ACTA PSYCHIATRICA SCANDINAVICA
- Psychedelics and Psychotherapy
- (2020) Sandeep Nayak et al. PHARMACOPSYCHIATRY
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
- (2020) Alan K. Davis et al. JAMA Psychiatry
- Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory
- (2019) Leor Roseman et al. JOURNAL OF PSYCHOPHARMACOLOGY
- REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics
- (2019) R. L. Carhart-Harris et al. PHARMACOLOGICAL REVIEWS
- Post-trial responsibilities beyond post-trial access
- (2018) Hae Lin Cho et al. LANCET
- When Ancillary Care Clashes with Study Aims
- (2017) Henry S. Richardson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
- (2016) Roland R Griffiths et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
- (2016) Stephen Ross et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Long-term follow-up of psilocybin-facilitated smoking cessation
- (2016) Matthew W. Johnson et al. AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE
- Attitudes toward Post-Trial Access to Medical Interventions: A Review of Academic Literature, Legislation, and International Guidelines
- (2015) Kori Cook et al. Developing World Bioethics
- Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population
- (2015) Peter S Hendricks et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
- (2015) Michael P Bogenschutz et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Emotional harm from disrespect: the neglected preventable harm
- (2015) Lauge Sokol-Hessner et al. BMJ Quality & Safety
- LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects
- (2014) Peter Gasser et al. JOURNAL OF PSYCHOPHARMACOLOGY
- World Medical Association Declaration of Helsinki
- (2013) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Forthcoming practical framework for ethics committees and researchers on post-trial access to the trial intervention and healthcare
- (2013) Neema Sofaer et al. JOURNAL OF MEDICAL ETHICS
- Psychedelics and Mental Health: A Population Study
- (2013) Teri S. Krebs et al. PLoS One
- Personality, Psychopathology, Life Attitudes and Neuropsychological Performance among Ritual Users of Ayahuasca: A Longitudinal Study
- (2012) José Carlos Bouso et al. PLoS One
- Reasons Why Post-Trial Access to Trial Drugs Should, or Need not be Ensured to Research Participants: A Systematic Review
- (2011) N. Sofaer et al. Public Health Ethics
- Adverse events in hospitals: the patient's point of view
- (2010) P. Masso Guijarro et al. QUALITY & SAFETY IN HEALTH CARE
- POST-TRIAL ACCESS TO ANTIRETROVIRALS: WHO OWES WHAT TO WHOM?
- (2009) JOSEPH MILLUM BIOETHICS
- Should post-trial provision of beneficial experimental interventions be mandatory in developing countries?
- (2008) Z. Zong JOURNAL OF MEDICAL ETHICS
- Human hallucinogen research: guidelines for safety
- (2008) MW Johnson et al. JOURNAL OF PSYCHOPHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started